524748 — Link Pharmachem Cashflow Statement
0.000.00%
- IN₹155.38m
- IN₹212.55m
- IN₹254.33m
- 65
- 59
- 51
- 65
Annual cashflow statement for Link Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 16.8 | 26.2 | 8.86 | -19.2 | -14 |
Depreciation | |||||
Non-Cash Items | 5.94 | 0.04 | 13.2 | 2.91 | 5.86 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 17 | -48 | -48.4 | 5.63 | 25.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 48.5 | -12.5 | -17.1 | -0.279 | 26.9 |
Capital Expenditures | -18.1 | -11.6 | -8.93 | -9.5 | -2.57 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -3.63 | -38.2 | 8.18 | 13.6 | 17.9 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -21.7 | -49.8 | -0.75 | 4.05 | 15.3 |
Financing Cash Flow Items | -4.4 | -4.51 | -7.61 | -8.72 | -7.75 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3.3 | 22.7 | 16.1 | -4.07 | -42.1 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 23.5 | -39.5 | -1.74 | -0.297 | 0.003 |